Summary & Overview
HCPCS G0252: PET Imaging for Initial Breast Cancer Diagnosis and Surgical Planning
HCPCS Level II code G0252 designates PET imaging using full- and partial-ring scanners for the initial diagnosis and surgical planning of breast cancer, including tasks such as initial axillary lymph node staging. Nationally, this imaging modality supports clinical decision-making by refining staging, guiding surgical approaches, and informing multidisciplinary care planning for patients with suspected or newly diagnosed breast cancer.
Key payers considered in this context include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise presentation of what the code covers, typical sites of service, and payer applicability. The publication summarizes clinical context for PET use in breast cancer, outlines common billing considerations, and highlights available benchmarks and policy updates where applicable. It also identifies service-line implications for radiology and oncology providers, and operational considerations for scheduling and site-of-service selection.
This summary is intended for a national audience and focuses on the code’s clinical role, billing classification, and areas where organizations typically seek clarity when submitting claims for initial diagnostic PET imaging and preoperative staging in breast cancer care.
Billing Code Overview
HCPCS Level II code G0252 describes positron emission tomography (PET) imaging performed with full- and partial-ring PET scanners for the initial diagnosis of breast cancer and/or surgical planning for breast cancer, such as initial staging of axillary lymph nodes.
Service Type: Diagnostic nuclear medicine imaging (PET) for breast cancer staging and surgical planning
Typical Site of Service: Hospital outpatient imaging centers, hospital radiology departments, and specialized outpatient PET/CT imaging centers
Clinical & Coding Specifications
Clinical Context
A 54-year-old woman presents after a core needle biopsy confirmed invasive ductal carcinoma of the right breast. Physical examination and diagnostic mammography suggest possible axillary lymph node involvement. The multidisciplinary breast team requests a PET scan using a full- or partial-ring PET scanner to assist with initial staging and surgical planning, particularly to evaluate axillary and extra-axillary nodal disease and to detect distant metastases prior to definitive surgery. The imaging appointment is scheduled at an outpatient imaging center equipped with PET/CT. On arrival, the patient is screened for diabetes and recent glucose control, receives radiotracer injection, rests quietly during uptake, and then undergoes PET imaging with CT for attenuation correction and anatomic localization. The interpreting physician documents findings, communicates results to the surgical and medical oncology team, and the facility bills the service under G0252 with appropriate modifier applied when applicable (for example 26 for professional component or TC for technical component).
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the physician interpretation/report by the radiologist or nuclear medicine physician. |